ARCHIVES

FDA Approves Bexxar For Treatment Of Non-Hodgkin’s Lymphoma.

This article is from The Cancer Letter archive.

Vol. 29 No. 27 | July 4, 2003

Download PDF Visit The Full Archive

Related Articles

FDA Hazleton Probe Finds Some Problems; Results Unaffected

April 23, 1976

Preserve NCI’s Role In Applied Research And Its Unique Environment, Chabner Says

May 12, 1995

Statement Defining Cancer Control Goals, Approaches Okayed By Board

February 6, 1981

NTP Board Okays Modification Of Bioassay Protocols

April 9, 1982

National Coalition for Cancer Research Formed To Support Reauthorization, l Research Budgets

April 19, 1985

First Clinical Guidelines On Ductal Lavage Published

March 29, 2002